Nevirapine is used for: HIV infection.
Recorded in the NepalDoc medicine catalog for Nevirapine.
Nevirapine tablets, USP are indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection. This indication is based on one principal clinical trial (BI 1090) that demonstrated prolonged suppression of HIV-1 RNA and two smaller supportive trials, one of which (BI 1046) is described below.
From the U.S. FDA-approved label for Nevirapine. Full label: DailyMed.
Nevirapine tablets, USP are indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection. This indication is based on one principal clinical trial (BI 1090) that demonstrated prolonged suppression of HIV-1 RNA and two smaller supportive trials, one of which (BI 1046) is described below. The 14-day lead-in period with Nevirapine tablets, USP 200 mg daily dosing must be strictly followed; it has been demonstrated to reduce the frequency of rash. If rash persists beyond the 14-day lead-in period, do not dose escalate to 200 mg twice daily.
From the U.S. FDA-approved label for Nevirapine. Full label: DailyMed.
If any patient experiences rash during the 14-day lead-in period, do not increase dose until the rash has resolved. 2.1 Adults The recommended dose for Nevirapine tablets, USP is one 200 mg tablet daily for the first 14 days, followed by one 200 mg tablet twice daily, in combination with other antiretroviral agents. The lead-in period has been observed to decrease the incidence of rash.
Directions from the U.S. FDA-approved label for Nevirapine — your doctor or pharmacist may advise differently.
Patients with moderate or severe (Child-Pugh Class B or C, respectively) hepatic impairment Use as part of occupational and non-occupational post-exposure prophylaxis (PEP) regimens, an unapproved use 4.1 Hepatic Impairment Nevirapine, USP is contraindicated in patients with moderate or severe (Child-Pugh Class B or C, respectively) hepatic impairment. 4.2 Post-Exposure Prophylaxis Nevirapine, USP is contraindicated for use as part of occupational and non-occupational post-exposure prophylaxis (PEP) regimens.
Excerpt from the U.S. FDA-approved label for Nevirapine. Talk to a pharmacist or doctor before use.
The most serious adverse reactions associated with Nevirapine are hepatitis/hepatic failure, Stevens-Johnson syndrome, toxic epidermal necrolysis, and hypersensitivity reactions. Hepatitis/hepatic failure may be associated with signs of hypersensitivity which can include severe rash or rash accompanied by fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, facial edema, eosinophilia, granulocytopenia, lymphadenopathy, or renal dysfunction.
Warnings and precautions excerpt from the U.S. FDA-approved label for Nevirapine — not a complete list. Talk to a pharmacist or doctor before use.
The most common adverse reaction is rash. In adults the incidence of rash is 15% vs 6% with placebo, with Grade 3/4 rash occurring in 2% of subjects In pediatric subjects the incidence of rash (all causality) was 21% To report SUSPECTED ADVERSE REACTIONS, contact Amneal Pharmaceuticals at 1-877-835-5472 or www.amneal.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Excerpt from the U.S. FDA-approved label for Nevirapine — not a complete list. Talk to a pharmacist or doctor about side effects.
4 brands · 2 makers in the NepalDoc catalog — see the full Nevirapine guide →
Storage Store below 30 ° C. Protect from light. Store in a safe place out of the reach of children.
Storage information from the U.S. FDA-approved label for Nevirapine.
What is Nevimune?
Nevimune Suspension is a Nevirapine medicine made by Cipla Ltd. It comes as Suspension.
What is Nevimune used for?
Nevirapine is used for HIV infection.
What is the generic name of Nevimune?
The generic name of Nevimune is Nevirapine.
Which brands of Nevirapine are available in Nepal?
4 brands of Nevirapine are listed in the NepalDoc catalog, from 2 makers — including Nelvir 250mg Tablet, Nevimune 200mg Tablet, Nevir 200mg Tablet.
What are the side effects of Nevirapine?
The most common adverse reaction is rash.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
